Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
The American Journal of Gastroenterology
|
March 15, 2018
Reply to Satta et al
Ali Rezaie, Satish S Rao
North American Journal of Medical Sciences
|
December 24, 2014
Association between fecal incontinence and objectively measured physical activity in u.s. Adults
Paul D Loprinzi, Satish S Rao
Current Gastroenterology Reports
|
January 19, 2016
How to Test and Treat Small Intestinal Bacterial Overgrowth: an Evidence-Based Approach
Ali Rezaie, Mark Pimentel, Satish S Rao
BMC Gastroenterology
|
January 3, 2024
Comparative profiles of lubiprostone, linaclotide, and elobixibat for chronic constipation: a systematic literature review with meta-analysis and number needed to treat/harm
Satish S Rao, Noriaki Manabe, Yusuke Karasawa, et al.
The Laryngoscope
|
October 31, 2009
Multifactorial dysphagia: diffuse idiopathic skeletal hyperostosis and eosinophilic esophagitis
Grace Nimmons, Douglas J Van Daele, Henry T Hoffman, et al.
Gastroenterology
|
October 1, 2021
Ulcerative Colitis Patients Have Reduced Rectal Compliance Compared With Non-Inflammatory Bowel Disease Controls
Noa Krugliak Cleveland, Victoria Rai, Katia El Jurdi, et al.
Digestive Diseases and Sciences
|
July 20, 2011
Long-term safety and effectiveness of lubiprostone, a chloride channel (ClC-2) activator, in patients with chronic idiopathic constipation
Anthony J Lembo, John F Johanson, Henry P Parkman, et al.
Neurogastroenterology and Motility
|
January 19, 2021
A multicenter study of anorectal pressures and rectal sensation measured with portable manometry in healthy women and men
Mayank Sharma, Ann C Lowry, Satish S Rao, et al.
Nature Reviews. Gastroenterology & Hepatology
|
June 7, 2018
Clinical measurement of gastrointestinal motility and function: who, when and which test?
Mark R Fox, Peter J Kahrilas, Sabine Roman, et al.
Gastroenterology
|
August 17, 2016
Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome
Anthony Lembo, Mark Pimentel, Satish S Rao, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
The American Journal of Gastroenterology
|
March 15, 2018
Reply to Satta et al
Ali Rezaie, Satish S Rao
North American Journal of Medical Sciences
|
December 24, 2014
Association between fecal incontinence and objectively measured physical activity in u.s. Adults
Paul D Loprinzi, Satish S Rao
Current Gastroenterology Reports
|
January 19, 2016
How to Test and Treat Small Intestinal Bacterial Overgrowth: an Evidence-Based Approach
Ali Rezaie, Mark Pimentel, Satish S Rao
BMC Gastroenterology
|
January 3, 2024
Comparative profiles of lubiprostone, linaclotide, and elobixibat for chronic constipation: a systematic literature review with meta-analysis and number needed to treat/harm
Satish S Rao, Noriaki Manabe, Yusuke Karasawa, et al.
The Laryngoscope
|
October 31, 2009
Multifactorial dysphagia: diffuse idiopathic skeletal hyperostosis and eosinophilic esophagitis
Grace Nimmons, Douglas J Van Daele, Henry T Hoffman, et al.
Gastroenterology
|
October 1, 2021
Ulcerative Colitis Patients Have Reduced Rectal Compliance Compared With Non-Inflammatory Bowel Disease Controls
Noa Krugliak Cleveland, Victoria Rai, Katia El Jurdi, et al.
Digestive Diseases and Sciences
|
July 20, 2011
Long-term safety and effectiveness of lubiprostone, a chloride channel (ClC-2) activator, in patients with chronic idiopathic constipation
Anthony J Lembo, John F Johanson, Henry P Parkman, et al.
Neurogastroenterology and Motility
|
January 19, 2021
A multicenter study of anorectal pressures and rectal sensation measured with portable manometry in healthy women and men
Mayank Sharma, Ann C Lowry, Satish S Rao, et al.
Nature Reviews. Gastroenterology & Hepatology
|
June 7, 2018
Clinical measurement of gastrointestinal motility and function: who, when and which test?
Mark R Fox, Peter J Kahrilas, Sabine Roman, et al.
Gastroenterology
|
August 17, 2016
Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome
Anthony Lembo, Mark Pimentel, Satish S Rao, et al.
Page
of 2